Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5857 posts found.

gilead-sciences

Gilead and MSD partner to develop and commercialise two-drug HIV regimen

March 16, 2021 Manufacturing and Production Gilead, HIV, MSD

Gilead and MSD, known as Merck in the US and Canada, have entered into an agreement to co-develop and co-commercialise …
News

Perception and Otsuka enter collaboration and licensing deal for depression drug candidate

March 16, 2021 Manufacturing and Production CNS, Otsuka Pharmaceutical, Perception Neuroscience, depression

Perception Neuroscience and Otsuka Pharmaceutical have announced a collaboration and licensing agreement for the development and commercialisation of Perception’s lead …
News

CytoDyn’s COVID-19 treatment shows positive results in Phase III trial

March 9, 2021 Manufacturing and Production cytodyn, phase 3 trial, vyrologix

Biotechnology company CytoDyn has shown positive results in its Phase III CD12 trial of Vyrologix, its treatment for COVID-19 patients …
News
FDA building

FDA approves Kite’s Yescarta therapy for follicular lymphoma

March 9, 2021 Manufacturing and Production FDA, Kite, Yescarta

The FDA has granted accelerated approval to Kite’s Yescarta treatment, a medicine for adult patients with relapsed or refractory follicular …
News
nuts-1736520_1920

Camallergy awarded £1.1m government funding for peanut allergy immunotherapy

March 9, 2021 Manufacturing and Production Camallergy, UK, allergy

Camallergy, a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced it has been awarded …
News

Valo and ImmunoScape collaboration identifies immunogenic peptides for pan-coronavirus vaccine

March 9, 2021 Manufacturing and Production COVID-19, Valo Therapeutics, immunoscape, vaccines

Immunotherapy platform developer Valo Therapeutics has successfully completed a collaboration with the biotechnology company ImmunoScape to identify immunogenic peptides for …
News
novartis_window

Novartis’ canakinumab fails to improve lung cancer survival in Phase III study

March 9, 2021 Manufacturing and Production Cancer, Novartis, lung cancer

Novartis has announced that the Phase III CANOPY-2 study evaluating canakinumab, an inhibitor of interleukin-1beta (IL-1β), in combination with the chemotherapy agent …
News

Verona Pharma appoints Novartis Gene Therapies VP Lisa Deschamps to its board

March 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, verona, verona pharma

Verona Pharma has appointed Lisa Deschamps, Senior Vice President and Chief Business Officer of Novartis Gene Therapies, as Non-Executive Director …
Appointment

SERB acquires BTG to expand its treatment portfolio for unmet medical needs

March 2, 2021 Manufacturing and Production BTG, SERB, specialty pharmaceuticals

SERB Specialty Pharmaceuticals has purchased BTG Specialty Pharmaceuticals, a division of Boston Scientific that develops treatments with critical conditions, for …
News

Single Pfizer or AstraZeneca vaccine dose drastically reduces COVID-19 hospitalisations in over-80s

March 2, 2021 Manufacturing and Production AstraZeneca, COVID-19, COVID-19 vaccine, Pfizer, Vaccine

A single dose of the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine reduces UK hospitalisations in over-80s by 80%, a Public Health …
News
sophie_biguenet_cmo_abivax

Abivax appoints Dr Sophie Biguenet as Chief Medical Officer

March 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotechnology company Abivax has appointed Dr Sophie Biguenet as Chief Medical Officer. Dr Biguenet brings 25 years of experience …
Appointment

Cancer Research UK joins forces with Teon to develop new cancer drug

March 2, 2021 Manufacturing and Production Cancer, Cancer Research UK, Teon

Cancer Research UK and Teon Therapeutics have entered a collaboration agreement to progress the early phase clinical development of Teon’s new cancer drug. The partnership …
News

CN Bio receives UK government grant to develop single and multi-organ models for COVID-19 research

March 2, 2021 Manufacturing and Production CN Bio, COVID-19

CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), has received a grant from innovation agency Innovate …
News

Iktos and Pfizer collaborate on AI drug design

March 2, 2021 Manufacturing and Production AI, Iktos, Pfizer

Iktos has announced that its artificial intelligence (AI) technology for de novo design will be applied to selected Pfizer small-molecule …
News
cov

MAPs during a global pandemic

February 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, MAPS

Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …
Feature
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026